Our testing results showed:
Figure 1: ASD and Biomarker Levels
Based on these initial findings we are developing a custom Quantibody® Antibody Array designed for the fine tuned testing of individuals with ASD. The biomarkers included in the array will be: HSP70, TGF-beta2,
Caspase-7, IFN-gamma and BDNF.
Figure 2: ASD Markers vs Controls
These panels will enable us to determine the severity of ASD. From the results, we will be working with our collaborators to determine potential cell based therapies for improving the symptom and behaviors of ASD sufferers. As part of the therapeutic regimes the panels can then be used check on progress towards "wellness".
This a key initiative for us in 2014 so stay tuned.